WO2002077153A3 - The human psychosine receptor - Google Patents

The human psychosine receptor Download PDF

Info

Publication number
WO2002077153A3
WO2002077153A3 PCT/US2001/043369 US0143369W WO02077153A3 WO 2002077153 A3 WO2002077153 A3 WO 2002077153A3 US 0143369 W US0143369 W US 0143369W WO 02077153 A3 WO02077153 A3 WO 02077153A3
Authority
WO
WIPO (PCT)
Prior art keywords
receptor
human
psychosine
tdag8
psychosine receptor
Prior art date
Application number
PCT/US2001/043369
Other languages
French (fr)
Other versions
WO2002077153A2 (en
Inventor
Kevin R Lynch
Dong Soon Im
Original Assignee
Univ Virginia
Kevin R Lynch
Dong Soon Im
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia, Kevin R Lynch, Dong Soon Im filed Critical Univ Virginia
Priority to AU2001297568A priority Critical patent/AU2001297568A1/en
Publication of WO2002077153A2 publication Critical patent/WO2002077153A2/en
Publication of WO2002077153A3 publication Critical patent/WO2002077153A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention is directed to the psychosine (galactosylsphingosine) receptor (named TDAG8), antibodies that specifically bind to that receptor, and the use of the receptor to identify agonists or antagonists of TDAG8 receptor activity.
PCT/US2001/043369 2000-11-20 2001-11-20 The human psychosine receptor WO2002077153A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001297568A AU2001297568A1 (en) 2000-11-20 2001-11-20 The human psychosine receptor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25206800P 2000-11-20 2000-11-20
US60/252,068 2000-11-20

Publications (2)

Publication Number Publication Date
WO2002077153A2 WO2002077153A2 (en) 2002-10-03
WO2002077153A3 true WO2002077153A3 (en) 2003-01-23

Family

ID=22954459

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/043369 WO2002077153A2 (en) 2000-11-20 2001-11-20 The human psychosine receptor

Country Status (2)

Country Link
AU (1) AU2001297568A1 (en)
WO (1) WO2002077153A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207412B1 (en) * 1997-11-13 2001-03-27 The Regents Of The University Of California Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207412B1 (en) * 1997-11-13 2001-03-27 The Regents Of The University Of California Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KYAW ET AL.: "Cloning, characterization and mapping of the human homolog of mouse T-cell death-associated gene", DNA AND CELL BIOLOGY, vol. 17, no. 6, 1998, pages 493 - 500, XP000929737 *

Also Published As

Publication number Publication date
WO2002077153A2 (en) 2002-10-03
AU2001297568A1 (en) 2002-10-08

Similar Documents

Publication Publication Date Title
WO1999017755A3 (en) Medicaments
YU42402A (en) Urea compounds having muscarinic receptor antagonist activity
AP2004002982A0 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain.
HK1029123A1 (en) Antibodies for inhibiting blood coagulation and methods of use thereof
MXPA02012712A (en) N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity.
PT1066380E (en) T SOLUVEL CELL RECEIVER
WO2003057838A3 (en) Antibodies against the muc18 antigen
WO2003057134A3 (en) Specific binding agents of human angiopoietin-2
WO2003057006A3 (en) Use of antibodies against the muc18 antigen
WO2002072536A8 (en) Urea derivatives having vanilloid receptor (vr1) antagonist activity
MXPA03000923A (en) Carboxamide compounds and their use as antagonists of a human 11cby receptor.
MXPA03009220A (en) Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors.
ID19253A (en) VITRONEKTIN RECEPTOR ANTAGONISTS, ITS MANUFACTURE AND USE OF IT
WO2005074985A3 (en) Methods of modulating cd200 and cd200r
WO1997010824A8 (en) Use of 5ht1b receptor antagonist for the treatment of vascular disease
IL145334A0 (en) The use of certain affinity nmda antagonists as antidepressants
WO2002017895A3 (en) Use of an aldosterone receptor antagonist to improve cognitive function
MA26907A1 (en) BICYCLIC CYCLOHEXYLAMINES AND THEIR USE AS ANTAGONISTS OF NMDA RECEPTORS.
WO2001098270A3 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
WO2001098269A3 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
IL151713A0 (en) Monoclonal antibodies to the human ldl receptor, their production and use
EA200601592A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PDE4 INHIBITOR OR PDE3 / 4 AND ANTAGONIST OF HISTAMINE RECEPTOR
WO2002068585A3 (en) Tip39 polypeptides
EP1246619A4 (en) Urotensin-ii receptor antagonists
WO2002047456A3 (en) Urotensin-ii receptor antagonists

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP